---
figid: PMC2014644__0706923f2
figtitle: PGE2-EP receptor signaling pathways
organisms:
- Mus musculus
- Homo sapiens
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC2014644
filename: 0706923f2.jpg
figlink: /pmc/articles/PMC2014644/figure/fig2/
number: F2
caption: 'PGE2-EP receptor signaling pathways. Four major types of EP receptors are
  involved in the signaling pathway mediated via different G proteins (p/q, αs and
  αi) using different second messenger. PGE2 induces intracellular Ca2+ or cAMP when
  it couples and signals through EP1 or EP2/4 receptors respectively. However, it
  reduces intracellular cAMP when it signals through EP3 receptors. Several different
  kinases are involved in PGE2 induced signaling pathways. PGE2-EP4 receptor coupling
  induces TNFα, cyclin D and angiogenesis using a specific pathway that is mediated
  via different MAP kinases. PGE2 also promotes cancer cell proliferation and inhibits
  apoptosis. It also induces COX-2 gene transcription and induces cell proliferation.
  On the other hand, it could also inhibit cell cycle through phosphorylation of Akt,
  GSK-3β and β-catenin. Abbreviations: AC, adenylate cyclase; DAG, diacylglycerol;
  IP3, inositol triphosphate; PIP2, phosphatidylinositol diphosphate; PKA, protein
  kinase A; PKC, protein kinase C; PI3K, phosphoinositide-3-kinase; Akt, protein kinase
  B; ERK, extracellular signal-regulated protein kinase; JNK, c-Jun N-terminal kinase;
  EGR-1, early growth response 1; EGFR, epidermal growth factor receptor; FGFR, fibroblast
  growth factor receptor; GSK-3, glycogen synthase kinase-3; ®, phosphorylation; ↑,
  up regulated; ↓, down regulated; X, inhibition.'
papertitle: Prostaglandin E2 receptor distribution and function in the gastrointestinal
  tract.
reftext: I Dey, et al. Br J Pharmacol. 2006 Nov;149(6):611-623.
year: '2006'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9499456
figid_alias: PMC2014644__F2
figtype: Figure
redirect_from: /figures/PMC2014644__F2
ndex: 56e3afd8-def4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2014644__0706923f2.html
  '@type': Dataset
  description: 'PGE2-EP receptor signaling pathways. Four major types of EP receptors
    are involved in the signaling pathway mediated via different G proteins (p/q,
    αs and αi) using different second messenger. PGE2 induces intracellular Ca2+ or
    cAMP when it couples and signals through EP1 or EP2/4 receptors respectively.
    However, it reduces intracellular cAMP when it signals through EP3 receptors.
    Several different kinases are involved in PGE2 induced signaling pathways. PGE2-EP4
    receptor coupling induces TNFα, cyclin D and angiogenesis using a specific pathway
    that is mediated via different MAP kinases. PGE2 also promotes cancer cell proliferation
    and inhibits apoptosis. It also induces COX-2 gene transcription and induces cell
    proliferation. On the other hand, it could also inhibit cell cycle through phosphorylation
    of Akt, GSK-3β and β-catenin. Abbreviations: AC, adenylate cyclase; DAG, diacylglycerol;
    IP3, inositol triphosphate; PIP2, phosphatidylinositol diphosphate; PKA, protein
    kinase A; PKC, protein kinase C; PI3K, phosphoinositide-3-kinase; Akt, protein
    kinase B; ERK, extracellular signal-regulated protein kinase; JNK, c-Jun N-terminal
    kinase; EGR-1, early growth response 1; EGFR, epidermal growth factor receptor;
    FGFR, fibroblast growth factor receptor; GSK-3, glycogen synthase kinase-3; ®,
    phosphorylation; ↑, up regulated; ↓, down regulated; X, inhibition.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PTGER3
  - PTGER4
  - PTGER2
  - SPAG11B
  - PTGER1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - MAPK1
  - MAPK3
  - CCND1
  - CCND2
  - CCND3
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - AKT1
  - AKT2
  - AKT3
  - EGR1
  - EGFR
  - GSK3B
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - CTNNB1
  - COX8A
  - CPOX
  - COX5A
  - COX5B
  - COX6C
  - COX7C
  - .na.character
  - COX4I1
  - COX4I2
  - COX6A1
  - COX6A2
  - COX6B1
  - COX6B2
  - COX7A1
  - COX7A2
  - COX7B
  - COX7B2
  - COX8C
  - ATP8A2
  - Ptger3
  - Ptger4
  - Ptger2
  - Ptger1
  - Lypd8l
  - Pik3r1
  - Mapk8
  - Ephb2
  - Mapk1
  - Creb1
  - Akt1
  - Egr1
  - Egfr
  - Gsk3b
  - Ctnnb1
  - Cox4i1
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - bsk
  - Erk7
  - rl
  - CycD
  - CrebB
  - CrebA
  - Akt
  - sgg
  - gskt
  - btl
  - htl
  - arm
  - CycE
  - cyc
  - COX4
  - ATPsynbeta
  - Atpalpha
  - PGE
  - Cancer
---
